How much does a box of pirtobrutinib cost?
Pirtobrutinib is a new type of targeted therapy drug that has been approved for marketing in China and is mainly used to treat certain types of hematological malignancies. Although it has been officially introduced in China, due to the short time on the market, it is still difficult to purchase it in domestic pharmacies or hospitals. Access channels for patients are relatively limited, and patients need to make an appointment through formal channels or contact a specialist to assist in purchasing drugs.
In overseas markets, the original drug of pitobrutinib is mainly divided into two types: European version and American version, which are relatively expensive. The latest market price is usually around 100,000 yuan per box, which is a large financial burden for many patients. Due to the high cost of drug research and development and technology patent protection, the price of original drugs is generally high, which is also an important factor that currently limits the widespread use of some patients.
In response to the high price issue, the Lao Ministry of Health approved a generic version of pitobrutinib produced by Lucius Pharmaceutical Factory. The specification of this version is 50mg*30 tablets, and the price is less than 3,000 yuan. The price advantage is obvious, which greatly reduces the patient's medication burden. The ingredients of generic drugs are basically the same as the original drugs and can provide similar therapeutic effects, making them an alternative chosen by many patients.
In general, although pitobrutinib is available in China, actual purchase is still difficult and the price is relatively high. Patients can consider purchasing original drugs through formal overseas channels, or choose generic drugs produced by Lucius in Laos to reduce treatment costs. No matter which drug is chosen, it is recommended that patients use the drug rationally under the guidance of a professional doctor to ensure efficacy and safety.
Reference materials:https://go.drugbank.com/drugs/DB17472
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)